Copyright: ©Author(s) 2026.
World J Clin Cases. Jun 6, 2026; 14(16): 119831
Published online Jun 6, 2026. doi: 10.12998/wjcc.v14.i16.119831
Published online Jun 6, 2026. doi: 10.12998/wjcc.v14.i16.119831
| Dimensions | Findings |
| Clinical domains | Oncology (dominant), cardiology, autoimmune disease |
| MDT composition | Oncologists, surgeons, radiologists, pathologists, geneticists, cardiologists, nurses, bioinformaticians |
| MDT format | In-person MDTs, molecular tumor boards, virtual/tele-MDTs |
| Innovation integrated | NGS, molecular profiling, AI/ML decision tools, liquid biopsy, precision therapeutics |
| Primary MDT function | Diagnostic clarification, treatment selection, escalation/de-escalation decisions |
| Outcomes reported | Diagnostic reclassification, altered management, feasibility of innovation integration |
| Survival/quality-of-life data | Limited direct reporting; mostly surrogate and process outcomes |
| Study design heterogeneity | Case reports → cohorts → qualitative and consensus studies |
| Geographic distribution | Europe, North America, Latin America |
- Citation: Gavkare AM, Nanaware NL, Darade R, Dhotre SV, Mumbre SS, Nagoba BS. Systematic review of multidisciplinary team strategies and novel research in rare and complex clinical cases. World J Clin Cases 2026; 14(16): 119831
- URL: https://www.wjgnet.com/2307-8960/full/v14/i16/119831.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i16.119831